Risperidone and clozapine combination for the treatment of refractory schizophrenia

被引：48
|
作者：
Morera, AL [1 ]
Barreiro, P
Cano-Muñoz, JL
机构：
[1] Univ La Laguna, Dept Med Interna & Psiquiatria, Fac Med, La Laguna 38320, Tenerife, Spain
[2] Hosp Psychiat, Tenerife, Spain
来源：
ACTA PSYCHIATRICA SCANDINAVICA | 1999年 / 99卷 / 04期
关键词：
schizophrenia; antipsychotic agents; clozapine; risperidone;
D O I：
10.1111/j.1600-0447.1999.tb07230.x
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Clozapine is the most widely used antipsychotic drug for the treatment of refractory schizophrenia. Here we report the case of two residual schizophrenic patients refractory to conventional antipsychotics who showed a poor response to atypical antipsychotics. The combination of risperidone and clozapine produced a noticeable improvement in the patients' clinical status and a shortening of the treatment response latency.
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [31] Lamotrigine-clozapine combination in refractory schizophrenia: Three cases
    Saba, G
    Dumortier, G
    Kalalou, K
    Benadhira, R
    Degrassat, K
    Glikman, J
    Januel, D
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2002, 14 (01) : 86 - 86
  • [32] Schizophrenia, violence, clozapine and risperidone: Review
    Taylor, PJ
    Butwell, M
    Gray, C
    Daly, R
    Delal, B
    Ferraro, D
    Gibb, R
    Heads, T
    Huckstep, B
    Larkin, E
    Leese, M
    Shetty, G
    Swinton, M
    Tidmarsh, D
    Williams, D
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1996, 169 : 21 - 30
  • [33] Anticholinergic activity of clozapine and risperidone in schizophrenia
    Tracy, JI
    Abraham, G
    Monaco, CA
    Pollock, BG
    Josiassen, RC
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 41 : 404 - 404
  • [34] Clozapine and risperidone in moderately refractory schizophrenia: A six month double-blind comparison
    Schooler, NR
    Marder, SR
    Kane, JM
    Wirshing, WC
    Chengappa, KNR
    Petrides, G
    Wirshing, DA
    McMeniman, M
    Parepally, H
    Umbricht, D
    Baker, RF
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 302 - 302
  • [35] ADJUNCTIVE RISPERIDONE IN CLOZAPINE TREATED PEOPLE WITH TREATMENT-RESISTANT SCHIZOPHRENIA
    Weiner, Elaine
    Ball, M. P.
    Feldman, S.
    Conley, R.
    Kelly, D.
    Gold, J. M.
    McMahon, R. P.
    Buchanan, R. W.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 358 - 358
  • [36] Nonresponse to clozapine and premorbid functioning in treatment refractory schizophrenia
    Kelly, Deanna L.
    Feldman, Stephanie
    Boggs, Douglas L.
    Gale, Elizabeth
    Conley, Robert R.
    [J]. COMPREHENSIVE PSYCHIATRY, 2010, 51 (03) : 298 - 302
  • [37] Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia
    Poyraz, Cana Aksoy
    Ozdemir, Armagano
    Saglam, Nazife Gamze Usta
    Turan, Senol
    Poyraz, Burc Cagri
    Tomruk, Nesrin
    Duran, Alaattin
    [J]. PSYCHIATRIC QUARTERLY, 2016, 87 (02) : 315 - 322
  • [38] Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel
    Ginsberg, G
    Shani, S
    Lev, B
    [J]. PHARMACOECONOMICS, 1998, 13 (02) : 231 - 241
  • [39] Effects of switching inpatients with treatment resistant schizophrenia from clozapine to risperidone
    Still, DJ
    Dorson, PG
    Crismon, ML
    Pousson, C
    [J]. PSYCHIATRIC SERVICES, 1996, 47 (12) : 1382 - 1384
  • [40] Cost-Benefit Analysis of Risperidone and Clozapine in the Treatment of Schizophrenia in Israel
    Gary Ginsberg
    Segev Shani
    Boaz Lev
    [J]. PharmacoEconomics, 1998, 13 : 231 - 241
12345